RecruitingPHASE2, PHASE3NCT03660917
Riluzole in Patients With Spinocerebellar Ataxia Type 7
Studying Spinocerebellar ataxia type 7
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- S. Andrea Hospital
- Intervention
- Riluzole(drug)
- Enrollment
- 34 enrolled
- Eligibility
- 7 years · All sexes
- Timeline
- 2021 – 2026
Study locations (1)
- Neurological Unit, S. Andrea Hospital, Faculty of Medicine and Psychology, "Sapienza" University of Rome, Rome, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT03660917 on ClinicalTrials.gov